<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04679402</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00107090</org_study_id>
    <nct_id>NCT04679402</nct_id>
  </id_info>
  <brief_title>Diaphragm Function and Diver Endurance</brief_title>
  <official_title>Diaphragm Function and Diver Endurance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Case Western Reserve University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will test the following hypotheses:&#xD;
&#xD;
        1. Training of the inspiratory muscles increases underwater endurance and reduces&#xD;
           hypercapnia in divers.&#xD;
&#xD;
        2. Inspiratory muscle training while breathing low concentration carbon monoxide (200 ppm)&#xD;
           for 30 minutes daily improves diaphragm performance to a greater degree than the same&#xD;
           training breathing air.&#xD;
&#xD;
        3. Inspiratory muscle training increases hypercapnia ventilatory response (gain) in those&#xD;
           individuals with a low gain.&#xD;
&#xD;
        4. Variability in oxygen (O2) and carbon dioxide (CO2) permeability of erythrocyte&#xD;
           membranes is a determining factor in underwater exercise performance.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aims of this project are to: (1) test a method that could increase personal endurance and&#xD;
      reduce excessive rise in blood carbon dioxide during underwater exercise in divers; and (2)&#xD;
      understand the mechanisms by which red blood cells transport oxygen and carbon dioxide and&#xD;
      their possible effects on exercise capacity. During underwater exercise, personal endurance&#xD;
      capacity and elevated blood PCO2 are key parameters that affect a diver's safety and&#xD;
      performance. Unlike exercise on dry land, hypercapnia often occurs during dives and can&#xD;
      impair cognitive function and predispose the diver to central nervous system (CNS) oxygen&#xD;
      toxicity and convulsions underwater. Some people intrinsically have low ventilatory&#xD;
      chemosensitivity, and are more likely to develop hypercapnia during a dive. Lack of stamina&#xD;
      may also be a mission-critical variable, and both endurance and the ability to control blood&#xD;
      carbon dioxide depend on the respiratory muscle (mainly diaphragm) function, for which&#xD;
      endurance capacity is related to mitochondrial number. Previous studies from our lab have&#xD;
      demonstrated increased mitochondrial biogenesis with training while breathing a low,&#xD;
      sub-toxic (200 ppm) level of carbon monoxide. In this study we will test the effect of daily&#xD;
      respiratory muscle training with and without added carbon monoxide on respiratory muscle&#xD;
      power, diaphragm thickness, respiratory muscle endurance and exercise endurance during a&#xD;
      subsequent dive to 50 feet of sea water. Arterial PCO2 and lactic acid levels will be&#xD;
      measured during exercise tests before and after training. Transport of O2 and CO2 through&#xD;
      erythrocyte cell membranes occurs mostly through channels. Erythrocytes from volunteers in&#xD;
      this study will be tested for O2 and CO2 permeability, and to correlate gas transport&#xD;
      efficiency with exercise performance and blood PCO2.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Mixed model with repeated measures</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>The only person who will know the breathing gas is the trial coordinator. Since carbon monoxide is a colorless, tasteless gas, the subject will be unaware of the group they are in. The gas labeling will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Underwater endurance change</measure>
    <time_frame>Baseline, 6 weeks</time_frame>
    <description>Endurance during continuous underwater exercise at a depth of 50 ft below the surface</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial PCO2 change</measure>
    <time_frame>Baseline, 6 weeks</time_frame>
    <description>Blood gases during and at end of exercise</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilatory chemosensitivity change</measure>
    <time_frame>Baseline, 6 weeks</time_frame>
    <description>Hypercapnic ventilatory response (VE.min-1.mmHg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Erythrocyte gas channel analysis</measure>
    <time_frame>Baseline</time_frame>
    <description>Stopped-flow analysis of O2 offloading from Hb of (a) intact RBCs, (b) Hb in hemolysate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Respiratory Muscles</condition>
  <arm_group>
    <arm_group_label>Respiratory Muscle Training Breathing Low Dose Carbon Monoxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carbon monoxide 200 ppm in air breathing during daily 30 minute inspiratory loading training sessions. Subjects will breathe the experimental gas through a mouthpiece with nose-clip in place.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Respiratory Muscle Training Breathing Air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Air breathing during daily 30 minute inspiratory loading training sessions. Subjects will breathe air through a mouthpiece with nose-clip in place.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Carbon monoxide 200 ppm in air</intervention_name>
    <description>Low dose carbon monoxide</description>
    <arm_group_label>Respiratory Muscle Training Breathing Air</arm_group_label>
    <arm_group_label>Respiratory Muscle Training Breathing Low Dose Carbon Monoxide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Normal volunteers&#xD;
&#xD;
          -  Non-smokers&#xD;
&#xD;
          -  Range of hypercapnic ventilatory responses&#xD;
&#xD;
          -  VO2peak ≥35 mL.kg-1.min-1 (males)&#xD;
&#xD;
          -  ≥30 mL.kg-1.min-1 (females)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Cardiorespiratory disease, including hypertension&#xD;
&#xD;
          -  Neuromuscular disease&#xD;
&#xD;
          -  Anemia&#xD;
&#xD;
          -  Hemoglobinopathy, including sickle cell disease and trait&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard E Moon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard E Moon, MD</last_name>
    <phone>9196848762</phone>
    <email>richard.moon@duke.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Natoli, MS</last_name>
    <phone>9196846726</phone>
    <email>michael.natoli@duke.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard E Moon, MD</last_name>
      <phone>919-684-8762</phone>
      <email>richard.moon@duke.edu</email>
    </contact>
    <contact_backup>
      <last_name>Michael Natoli, MS</last_name>
      <phone>919-684-6726</phone>
      <email>michael.natoli@duke.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 17, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 22, 2020</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Control of breathing</keyword>
  <keyword>Diaphragm function</keyword>
  <keyword>Gas channels</keyword>
  <keyword>Blood gases</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carbon Monoxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

